Skip to main content

and
  1. No Access

    Article

    Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus

    Osamu Imataki, Haruyuki Fujita, Makiko Uemura in International Journal of Hematology (2024)

  2. No Access

    Article

    Comprehensive procedure for injecting Evusheld® for hematological diseases in a single institute

    Tixagevimab and cilgavimab (EVA, Evusheld®), monoclonal antibody combination treatments, consisted of two neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). EVA showe...

    Osamu Imataki, Shunsuke Yoshida, Tomoya Ishida, Makiko Uemura in Annals of Hematology (2024)

  3. No Access

    Article

    Multifocal osteonecrosis after stem cell transplantation

    Osamu Imataki, Makiko Uemura in International Journal of Hematology (2022)

  4. No Access

    Article

    Anemia and hypogammaglobulinemia caused by Ménétrier’s disease

    Osamu Imataki, Shumpei Uchida, Shigeyuki Yokokura in International Journal of Hematology (2018)

  5. No Access

    Article

    Clinical impact of sarcopenia and relevance of nutritional intake in patients before and after allogeneic hematopoietic stem cell transplantation

    We conducted a retrospective study to evaluate the effect of rehabilitation on minimizing sarcopenia during hematopoietic stem cell transplantation (HSCT) therapy.

    Shouichi Tanaka, Osamu Imataki in Journal of Cancer Research and Clinical On… (2017)

  6. No Access

    Article

    Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation

    Anti-thymocyte globulin (ATG) administered at 5–10 mg/kg can prevent graft-versus-host disease (GVHD). We sought to investigate the potential for lower doses of ATG to decrease non-relapse mortality (NRM).

    Osamu Imataki, Kensuke Matsumoto in Journal of Cancer Research and Clinical On… (2017)

  7. No Access

    Article

    Paradoxical thrombosis in idiopathic thrombocytopenic purpura

    Osamu Imataki, Shumpei Uchida, Shigeyuki Yokokura in International Journal of Hematology (2017)

  8. No Access

    Article

    Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor

    Although the Sokal and Hasford scoring systems are well-known prognostic models specific to chronic myeloid leukemia (CML), whether they can effectively predict outcomes in elderly CML patients with comorbidit...

    Makiko Uemura, Osamu Imataki, Yasunori Kawachi in International Journal of Hematology (2016)

  9. No Access

    Article

    Delayed flare reaction of draining vein due to subcutaneous bortezomib more likely to occur at the inner thigh

    Osamu Imataki, Sayoko Ota, Mariko Aoyama in International Journal of Hematology (2015)

  10. No Access

    Article

    NKT cell-infiltrating aseptic meningitis on the central nervous system in Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib

    Osamu Imataki, Takeshi Arai, Genji Yamaoka, Akihito Matsuoka in Annals of Hematology (2014)

  11. No Access

    Article

    Reversible cerebral vasoconstriction syndrome resulted in cerebral infarction after allogeneic stem cell transplantation: a case report

    Osamu Imataki, Makiko Uemura, Takamichi Shintani, Kensuke Matsumoto in Annals of Hematology (2014)

  12. No Access

    Article

    Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formation

    Fibronectin (FN) plays important roles in the proliferation, differentiation, and maintenance of megakaryocytic-lineage cells through FN receptors. However, substantial role of FN receptors and their functiona...

    Takuya Matsunaga, Fumio Fukai, Takuro Kameda, Kotaro Shide in Annals of Hematology (2012)